Stock Dividends
Nutriband Inc. Ties Shareholder Rewards to FDA Approval Milestone with 25% Preferred Stock Dividend
Nutriband Inc. (NASDAQ: NTRB) has announced a 25% preferred stock dividend, linking shareholder rewards directly to the FDA approval process for its lead product, AVERSA(TM) Fentanyl, highlighting the significance of regulatory achievements in biopharmaceutical value creation.
Nutriband Inc. Announces Key Dates for 25% Preferred Stock Dividend
Nutriband Inc. (NASDAQ: NTRB) has set important dates for its 25% preferred stock dividend, linking the dividend's value to the FDA approval of its AVERSA Fentanyl product, marking a significant milestone for shareholders and the company's growth in the pharmaceutical sector.
Nutriband Inc. Announces 25% Preferred Stock Dividend Tied to AVERSA Fentanyl FDA Approval
Nutriband Inc. (NASDAQ: NTRB) has declared a 25% preferred stock dividend, contingent on FDA approval of its AVERSA Fentanyl product, highlighting its strategy to enhance shareholder value during the product's commercialization phase.